Researcher: Dra. Raquel Pérez López Center: : Vall d’Hebron Institute of Oncology, Barcelona Introduction: Cancer immunotherapy has brought about a radical change in the way in which many types of cancer are treated. However, although has fantastic results in some patients, in a significant percentage such therapies are ineffective. Knowing which patients have a greater or lesser chance of responding is one of the biggest challenges of modern medicine: it
CRIS PROGRAMME OF EXCELLENCE 2019 Researcher: Dr. David Olmos Center: : Centro Nacional de Investigaciones Oncológicas, Madrid Introduction: In developed countries, prostate cancer is the most commonly occurring tumour in males. Generally, most patients are diagnosed in the early stages when the tumour is still localized and are usually cured. However, in 5-10% of patients, diagnosis occurs when the tumour has
Principal Researcher: Dra. Clara Montagut Viladot Center: Hospital del Mar Investigacions Mèdiques Biography: Clara Montagut graduated from the Autonomous University of Barcelona with a degree in Medicine and Surgery and trained in medical oncology at the Hospital Clínic. She specialized in translational cancer research, specifically in biomarkers and mechanisms of resistance to biological drugs at the Hospital Clínic itself and at the Massachusetts General Hospital Cancer Center (Harvard